Effects of the Rho-kinase inhibitor, fasudil, on pulmonary hypertension

Circ J. 2015;79(6):1213-4. doi: 10.1253/circj.CJ-15-0443. Epub 2015 Apr 30.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / therapeutic use
  • Female
  • Heart Defects, Congenital / complications*
  • Hemodynamics / drug effects*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Male
  • Molecular Targeted Therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Vasodilator Agents / therapeutic use*
  • rho-Associated Kinases / antagonists & inhibitors*

Substances

  • Protein Kinase Inhibitors
  • Vasodilator Agents
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • rho-Associated Kinases
  • fasudil